ABBVIE
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries.
ABBVIE
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2013-01-01
Address:
Chicago, Illinois, United States
Country:
United States
Website Url:
http://www.abbvie.com
Total Employee:
10001+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving Apache Mobile Non Scaleable Content Nginx Euro
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Advisor
2020-01-01
Board_member
Board_member
Advisor
2014-07-01
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Tariq Ghayur Distinguished Research Fellow @ AbbVie
Distinguished Research Fellow
2013-11-01
Ric A. Gonzalez Chief Executive Officer @ AbbVie
Chief Executive Officer
Sanjay Nilapwar Principal Scientist @ AbbVie
Principal Scientist
2020-10-01
James Holdsworth Architect, Technology II @ AbbVie
Architect, Technology II
2020-04-01
Arminda Montero Program Manager, Global Supply Chain QA @ AbbVie
Program Manager, Global Supply Chain QA
Kimberley Hockley Benefit Risk Manager @ AbbVie
Benefit Risk Manager
2020-09-01
Henry Gosebruch EVP and Chief Strategy Officer @ AbbVie
EVP and Chief Strategy Officer
2015-01-01
Amanda Graber Rosenberg Global Communications Strategy & Planning @ AbbVie
Global Communications Strategy & Planning
2021-05-01
Philip Hajduk Vice President @ AbbVie
Vice President
2016-01-01
Adiba Ishaque-Zanghi Principal Research Scientist I @ AbbVie
Principal Research Scientist I
2019-11-01
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-03-01 | Syndesi Therapeutics | Syndesi Therapeutics acquired by AbbVie | 1000 M USD |
| 2021-03-10 | Mitokinin | Mitokinin acquired by AbbVie | N/A |
| 2019-07-15 | Mavupharma | Mavupharma acquired by AbbVie | N/A |
| 2019-06-25 | Allergan | Allergan acquired by AbbVie | 63 B USD |
| 2016-04-28 | Stemcentrx | Stemcentrx acquired by AbbVie | 5.8 B USD |
| 2015-03-04 | Pharmacyclics | Pharmacyclics acquired by AbbVie | 21 B USD |
| 2014-01-01 | ImmuVen | ImmuVen acquired by AbbVie | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-08-31 | Eskenazi Health | AbbVie investment in Grant - Eskenazi Health | N/A |
| 2021-06-09 | Kojin Therapeutics | AbbVie investment in Series A - Kojin Therapeutics | 60 M USD |
| 2021-04-29 | Capsida | AbbVie investment in Corporate Round - Capsida | 90 M USD |
| 2020-12-09 | Year Up | AbbVie investment in Grant - Year Up | 10 M USD |
| 2019-12-03 | Inventiva Pharma | AbbVie investment in Grant - Inventiva Pharma | 3.5 M USD |
| 2018-12-03 | St Jude Children’s Research Hospital | AbbVie investment in Grant - St Jude Children’s Research Hospital | 50 M USD |
| 2017-04-25 | Aquinnah Pharmaceuticals | AbbVie investment in Venture Round - Aquinnah Pharmaceuticals | 10 M USD |
| 2016-01-11 | Lodo Therapeutics | AbbVie investment in Series A - Lodo Therapeutics | 17 M USD |
| 2016-01-06 | Petra Pharma | AbbVie investment in Series A - Petra Pharma | 48 M USD |
Newest Events participated
Participated in BIO-Europe 2017 | November 6–8 in Berlin, Germany
on 2017-11-06 as exhibitor
Participated in BIO-Europe 2017 | November 6–8 in Berlin, Germany
on 2017-11-06 as sponsor
Participated in American Association of Nurse Anesthetists (AANA) 2017 Annual Congress
on 2017-09-08 as exhibitor
Participated in impact'17
on 2017-05-31 as sponsor
Participated in Vitalis 2017
on 2017-04-25 as exhibitor
Participated in Rock Health Summit
on 2015-09-29 as sponsor
Participated in Digital Health Days
on 2015-09-23 as sponsor
Key Employee Changes
| Date | New article |
|---|---|
| 2020-11-13 | AbbVie lifts insider Jeffrey Stewart to commercial chief as company veteran Carlos Alban retires |
Official Site Inspections
http://www.abbvie.com Semrush global rank: 102.29 K Semrush visits lastest month: 963.93 K
- Host name: 159.180.132.176
- IP address: 159.180.132.176
- Location: North Chicago United States
- Latitude: 42.325
- Longitude: -87.8561
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60064
More informations about "AbbVie"
Our Company - AbbVie
At AbbVie, we combine advanced science, expertise and passion to solve serious health issues and have a remarkable impact on people’s lives. ... Signed and dated letter of request on your …See details»
About AbbVie - Our Company | AbbVie
AbbVie may have been founded in 2013, but our roots run deep. In 2013, we became a separate company from Abbott, though we share a common legacy and strong prospects for future success. ... Signed and dated letter of request …See details»
Our Leaders | AbbVie - Pharmaceutical Research & Development
Oct 24, 2024 Our board members work closely with AbbVie leaders to maintain our focus of putting patients first. Richard A. Gonzalez. Executive Chairman of the Board and Retired Chief …See details»
Pharmaceutical Research & Development - AbbVie
AbbVie will support initiatives that promote health equity, delivery of care, and improved outcomes and access for patients. ... Signed and dated letter of request on your organization’s …See details»
AbbVie - Wikipedia
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois.It is ranked sixth on the list of largest biomedical companies by revenue.In 2023, the company's …See details»
Pharmaceutical Research & Development | AbbVie
As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact …See details»
Our Company - AbbVie
AbbVie was founded in 2013 when we became a separate company from Abbott. Our name represents a proud connection to that legacy. AbbVie formed a new kind of enterprise – a biopharmaceutical company – with the stability, global …See details»
Governance - AbbVie
At AbbVie, we pride ourselves in our long tradition of strong financial controls and corporate governance. AbbVie's Board of Directors plays a vital role in providing strategic direction and …See details»
About AbbVie - Our Company | AbbVie - abbvie.com.my
AbbVie may have been founded in 2013, but our roots run deep. In 2013, we became a separate company from Abbott, though we share a common legacy and strong prospects for future …See details»
Who We Are | AbbVie
The AbbVie webpage you have requested is only intended for certain countries. (You will find the relevant information on the page.) Therefore, the website may contain information on medicinal products, other products or uses of these …See details»
Our Company - AbbVie
The AbbVie Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on …See details»
Org Chart AbbVie - The Official Board
The organizational chart of AbbVie displays its 268 main executives including Robert Michael, Scott Reents and Azita Saleki-GerhardtSee details»
Our Principles - AbbVie
Oct 24, 2024 Operating as one AbbVie team, we care deeply for our patients, their families, our employees, and our communities. We strive to always do the right thing, pursuing the highest …See details»
About AbbVie - Our Company | AbbVie
AbbVie may have been founded in 2013, but our roots run deep. In 2013, we became a separate company from Abbott, though we share a common legacy and strong prospects for future …See details»
At A Glance - Our Company - AbbVie
The AbbVie Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on …See details»
Key Facts - AbbVie
Oct 24, 2024 AbbVie’s 2024 Working Parents: Finding Purpose in Adversity. AbbVie’s 2024 Working Parents honorees not only overcame major obstacles—they channeled their …See details»
AbbVie’s Howard Jacob on using data to find cures | McKinsey
6 days ago Howard Jacob: I was hired to lead the AbbVie Genomics Research Center, a global organization that covers data generation for omics 1 Omics are various disciplines in biology …See details»
Czech National Bank Has $68.09 Million Stake in AbbVie Inc
1 day ago Finally, ORG Wealth Partners LLC grew its stake in AbbVie by 13.9% in the 4th quarter. ORG Wealth Partners LLC now owns 14,808 shares of the company's stock valued at …See details»
AbbVie: Who we are
AbbVie: Who we are US-ABBV-200135 At AbbVie, we strive to make a remarkable impact on the lives of patients. 2. AbbVie: Who we are US-ABBV-200135 AbbVie has as long history in …See details»
At a Glance - Our Company | AbbVie
AbbVie Corporation in Canada: ... Signed and dated letter of request on your organization’s letterhead. Detailed budget breakdown; Article of Incorporation (or any legal document …See details»